PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA

被引：0
|
作者：
Kebir, Sied [1 ]
Lazaridis, Lazaros [1 ]
Schmidt, Teresa [1 ]
Oster, Christoph [2 ]
Pierscianek, Daniela [3 ]
Guberina, Nika [2 ]
Kleinschnitz, Christoph [4 ]
Proescholdt, Martin [5 ]
Hau, Peter [5 ]
Grosu, Anca-Ligia [6 ]
Sure, Ulrich [3 ]
Scheffler, Bjoern [2 ]
Stuschke, Martin [7 ]
Glas, Martin [1 ]
机构：
[1] Univ Hosp Essen, Div Clin Neurooncol, Dept Neurol, Essen, Germany
[2] Univ Hosp Essen, Essen, Germany
[3] Univ Hosp Essen, Dept Neurosurg, Essen, Germany
[4] Univ Hosp Essen, Dept Neurol, Essen, Germany
[5] Univ Hosp Regensburg, Regensburg, Germany
[6] Univ Hosp Freiburg, Freiburg, Germany
[7] Univ Hosp Essen, Dept Radiotherapy, Essen, Germany
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CTNI-79
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [21] A Phase I/II Clinical Trial of Hyperfractionated Concomitant Boost Proton Radiotherapy for Supratentorial Glioblastoma Multiforme
    Tsuboi, K.
    Mizumoto, M.
    Igaki, H.
    Yamamoto, T.
    Takano, S.
    Okumura, T.
    Sakurai, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S231 - S231
  • [22] SYMPTOM BURDEN IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA UNDERGOING RADIOTHERAPY PLUS TEMOZOLOMIDE AND ENZASTAURIN: RESULTS FROM A PHASE I/II TRIAL
    Butowski, Nicholas
    Parvataneni, Rupa
    Nicole, Angelina
    Lamborn, Kathleen
    Polley, Mei
    Clarke, Jennifer
    Chang, Susan
    Page, Margaretta
    Prados, Michael
    Liepa, Astra
    Shi, P.
    Thornton, Donald
    NEURO-ONCOLOGY, 2010, 12 : 104 - 104
  • [23] A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma
    Werlenius, Katja
    Stragliotto, Giuseppe
    Strandeus, Michael
    Blomstrand, Malin
    Caren, Helena
    Jakola, Asgeir S.
    Rydenhag, Bertil
    Dyregaard, Dorte
    Dzhandzhugazyan, Karine N.
    Kirkin, Alexei F.
    Raida, Martin K.
    Smits, Anja
    Kinhult, Sara
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [24] Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma
    Faye, Mame Daro
    Easaw, Jacob
    De Robles, Paula
    Agnihotram, Raman
    Torres-Vasquez, Alexander
    Lamonde, Frederic
    Petrecca, Kevin
    Owen, Scott
    Panet-Raymond, Valerie
    Shenouda, George
    Souhami, Luis
    Azam, Maryam
    Hossain, Bushra
    Alkass, Jad
    Sabri, Siham
    Abdulkarim, Bassam
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
  • [25] Glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
    Vaz, M. A.
    del Barco, S.
    Sepulveda, J. M.
    Alonso, M.
    Pineda, E.
    Balana, C.
    Martinez-Garcia, M.
    Girones, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S393 - S393
  • [26] A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Saran, Frank
    James, Allan
    McBain, Catherine
    Jefferies, Sarah
    Harris, Fiona
    Cseh, Agnieszka
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Brada, Michael
    NEURO-ONCOLOGY, 2018, 20 : 20 - 20
  • [27] Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial
    Compter, Inge
    Eekers, Danielle B. P.
    Hoeben, Ann
    Rouschop, Kasper M. A.
    Reymen, Bart
    Ackermans, Linda
    Beckervordersantforth, Jan
    Bauer, Noel J. C.
    Anten, Monique M.
    Wesseling, Pieter
    Postma, Alida A.
    De Ruysscher, Dirk
    Lambin, Philippe
    AUTOPHAGY, 2021, 17 (09) : 2604 - 2612
  • [28] A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma
    Brown, Paul D.
    Chung, Caroline
    Liu, Diane D.
    McAvoy, Sarah
    Grosshans, David
    Al Feghali, Karine
    Mahajan, Anita
    Li, Jing
    McGovern, Susan L.
    Mcaleer, Mary-Fran
    Ghia, Amol J.
    Sulman, Erik P.
    Penas-Prado, Marta
    de Groot, John F.
    Heimberger, Amy B.
    Wang, Jihong
    Armstrong, Terri S.
    Gilbert, Mark R.
    Guha-Thakurta, Nandita
    Wefel, Jeffrey S.
    NEURO-ONCOLOGY, 2021, 23 (08) : 1337 - 1347
  • [29] Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial)
    Supriya Mallick
    Haresh Kunhiparambath
    Subhash Gupta
    Rony Benson
    Seema Sharma
    M. A. Laviraj
    Ashish Datt Upadhyay
    Pramod Kumar Julka
    Dayanand Sharma
    Goura Kishor Rath
    Journal of Neuro-Oncology, 2018, 140 : 75 - 82
  • [30] Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial)
    Mallick, Supriya
    Kunhiparambath, Haresh
    Gupta, Subhash
    Benson, Rony
    Sharma, Seema
    Laviraj, M. A.
    Upadhyay, Ashish Datt
    Julka, Pramod Kumar
    Sharma, Dayanand
    Rath, Goura Kishor
    JOURNAL OF NEURO-ONCOLOGY, 2018, 140 (01) : 75 - 82
12345